Crispr Therapeutics shares owned by Jacob Asset Management of New York
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Jacob Asset Management of New York
from 13F filings
Historical chart of Jacob Asset Management of New York investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Jacob Asset Management of New York consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by Jacob Asset Management of New York
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $182k | 4.0k | 45.39 |
| 2023-06-30 | $203k | 3.6k | 56.14 |
| 2023-03-31 | $164k | 3.6k | 45.23 |
| 2022-12-31 | $134k | 3.3k | 40.65 |
| 2022-09-30 | $173k | 2.6k | 65.48 |
| 2022-06-30 | $176k | 2.9k | 60.73 |
| 2022-03-31 | $182k | 2.9k | 62.80 |
| 2021-12-31 | $220k | 2.9k | 75.81 |
| 2021-09-30 | $64k | 573 | 111.69 |
More positions owned by Jacob Asset Management of New York
Block Cl A (SQ)
View all positions for Jacob Asset Management of New York